Tanguler Tolga (CIK 1849458) reported 88 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-06). Recent activity: Sell ALNY (102 shares), Sell ALNY (350 shares), Sell ALNY (215 shares), Sell ALNY (289 shares), Sell ALNY (106 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-06 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | EVP, Chief Commercial Officer | Sell | 102 | $32,641 |
| 2026-03-06 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | EVP, Chief Commercial Officer | Sell | 350 | $113,054 |
| 2026-03-06 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | EVP, Chief Commercial Officer | Sell | 215 | $68,974 |
| 2026-03-06 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | EVP, Chief Commercial Officer | Sell | 289 | $93,006 |
| 2026-03-06 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | EVP, Chief Commercial Officer | Sell | 106 | $33,817 |
| 2026-03-06 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | EVP, Chief Commercial Officer | Sell | 767 | $248,385 |
| 2026-03-06 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | EVP, Chief Commercial Officer | Sell | 272 | $88,367 |
| 2026-03-06 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | EVP, Chief Commercial Officer | Sell | 208 | $67,739 |
| 2026-03-04 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | EVP, Chief Commercial Officer | Sell | 329 | $107,803 |
| 2026-03-04 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | EVP, Chief Commercial Officer | Sell | 47 | $15,210 |
| 2026-03-04 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | EVP, Chief Commercial Officer | Sell | 90 | $29,218 |
| 2026-03-04 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | EVP, Chief Commercial Officer | Sell | 258 | $84,013 |
| 2026-03-04 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | EVP, Chief Commercial Officer | Buy | 4,769 | $0 |
| 2026-03-04 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | EVP, Chief Commercial Officer | Sell | 100 | $32,871 |
| 2026-03-04 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | EVP, Chief Commercial Officer | Sell | 170 | $56,051 |
| 2026-03-04 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | EVP, Chief Commercial Officer | Sell | 81 | $26,799 |
| 2026-03-04 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | EVP, Chief Commercial Officer | Sell | 94 | $31,201 |
| 2026-03-04 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | EVP, Chief Commercial Officer | Sell | 37 | $12,308 |
| 2026-03-04 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | EVP, Chief Commercial Officer | Sell | 392 | $128,110 |
| 2026-03-02 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | EVP, Chief Commercial Officer | Buy | 1,666 | $0 |
| 2026-02-17 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | EVP, Chief Commercial Officer | Buy | 4,000 | $0 |
| 2026-02-17 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | EVP, Chief Commercial Officer | Sell | 1,959 | $607,447 |
| 2026-01-14 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | EVP, Chief Commercial Officer | Sell | 42 | $14,917 |
| 2026-01-14 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | EVP, Chief Commercial Officer | Buy | 3,800 | $0 |
| 2026-01-14 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | EVP, Chief Commercial Officer | Sell | 39 | $13,804 |
Source: SEC Form 4 filings · as of 2026-03-06